Is a complete ARCT research report available?

No complete published report is available for Arcturus Therapeutics Holdings Inc. (ARCT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Arcturus Therapeutics Holdings Inc. (ARCT)

NASDAQ: ARCT · USD

$12.1

+0.83 (+7.4%)· Recorded snapshot

Market cap	342.8M
Revenue (ttm)	29.4M
Net income (ttm)	-93.3M
EPS (ttm)	-$3.33
Shares out	28.4M
Volume	589,438
Beta	2.48

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 29.4M
Net income (ttm): -93.3M
EPS (ttm): -$3.33
Market cap: 342.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001768224
Company name	Arcturus Therapeutics Holdings Inc.
Country	United States
Country code	US
CUSIP number	03969T109
Earnings date	2026-11-05
Earnings time	amc
Employees	111
Employees change	-65
Employees growth	-36.93%
Enterprise value	$174.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2013
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US03969T1097
Last 10-K release date	2026-03-03
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$342.8M
Market cap category	Small-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$12.06
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ARCT
U.S. state	California
Website	https://arcturusrx.com

Metric

Value

Amount currency

USD

CIK code

0001768224

Company name

Arcturus Therapeutics Holdings Inc.

Country

United States

Country code

CUSIP number

03969T109

Earnings date

2026-11-05

Earnings time

amc

Employees

111

Employees change

-65

Employees growth

-36.93%

Enterprise value

$174.2M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2013

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US03969T1097

Last 10-K release date

2026-03-03

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$342.8M

Market cap category

Small-Cap

Next earnings date

2026-11-05

Options

Yes

Price

$12.06

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

ARCT

U.S. state

California

Website

https://arcturusrx.com

Metric	Value
Earnings yield	-27.59%
EV/Sales	5.77x
FCF / EV yield	-42.99%
FCF yield	-21.55%
Forward EV/Sales	9.44x
Forward P/S	18.83x
P/B ratio	1.86x
P/S ratio	11.51x
Price / tangible book value	1.97x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-27.59%

EV/Sales

5.77x

FCF / EV yield

-42.99%

FCF yield

-21.55%

Forward EV/Sales

9.44x

Forward P/S

18.83x

P/B ratio

1.86x

P/S ratio

11.51x

Price / tangible book value

1.97x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Gross margin	-195.5%
Operating margin	-348.32%
Pretax margin	-317.62%
Profit per employee	$-840,324
Revenue per employee	$264,577
ROA	-23.96%
ROA (5Y)	-13.89%
ROCE	-53.62%
ROE	-46.31%
ROE (5Y)	-26.47%
ROIC	-2,828.93%
SBC / revenue	71.85%
Tax / revenue	-0.01%

Metric

Value

Gross margin

-195.5%

Operating margin

-348.32%

Pretax margin

-317.62%

Profit per employee

$-840,324

Revenue per employee

$264,577

ROA

-23.96%

ROA (5Y)

-13.89%

ROCE

-53.62%

ROE

-46.31%

ROE (5Y)

-26.47%

ROIC

-2,828.93%

SBC / revenue

71.85%

Tax / revenue

-0.01%

Metric	Value
EPS growth years	1
Net income growth years	1
Revenue growth	-75.95%
Revenue growth (Q)	-89.55%
Revenue growth (QoQ)	43.57%
Revenue growth 3Y	-51.93%
Revenue growth 5Y	27.55%
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth

-75.95%

Revenue growth (Q)

-89.55%

Revenue growth (QoQ)

43.57%

Revenue growth 3Y

-51.93%

Revenue growth 5Y

27.55%

Revenue growth years

Metric	Value
Capital expenditures	$-93,000
Depreciation and amortization	$2.7M
EBIT	$-102.3M
EBITDA	$-99.5M
EPS	$-3.33
FCF per share	$-2.56
Financing cash flow	$12.9M
Free cash flow	$-72.8M
Free cash flow minus SBC	$-93.9M
Gross profit	$-57.4M
Income taxes	$-4,000
Investing cash flow	$-41,000
Net cash flow	$-59.8M
Net income	$-93.3M
Operating cash flow minus SBC	$-93.8M
Operating income	$-102.3M
Revenue	$29.4M
Stock-based compensation	$21.1M

Metric

Value

Capital expenditures

$-93,000

Depreciation and amortization

$2.7M

EBIT

$-102.3M

EBITDA

$-99.5M

EPS

$-3.33

FCF per share

$-2.56

Financing cash flow

$12.9M

Free cash flow

$-72.8M

Free cash flow minus SBC

$-93.9M

Gross profit

$-57.4M

Income taxes

$-4,000

Investing cash flow

$-41,000

Net cash flow

$-59.8M

Net income

$-93.3M

Operating cash flow minus SBC

$-93.8M

Operating income

$-102.3M

Revenue

$29.4M

Stock-based compensation

$21.1M

Metric	Value
Altman Z-Score	-0.68
Book value per share	$6.04
Debt / equity	0.13
Interest coverage	-11,366
Long-term assets	$27.1M
Long-term liabilities	$19M
Net cash (debt)	$168.6M
Net cash / market cap	49.87%
Net cash growth	-0.56%
Net debt / equity	-0.98
Piotroski F-Score	1
Property, plant and equipment	$25.1M
Shareholders' equity	$171.8M
Tangible book value	$171.8M
Tangible book value per share	$6.04
Total assets	$224.3M
Total cash	$191.5M
Total debt	$22.9M
Total liabilities	$52.5M
WACC	16.77%

Metric

Value

Altman Z-Score

-0.68

Book value per share

$6.04

Debt / equity

0.13

Interest coverage

-11,366

Long-term assets

$27.1M

Long-term liabilities

$19M

Net cash (debt)

$168.6M

Net cash / market cap

49.87%

Net cash growth

-0.56%

Net debt / equity

-0.98

Piotroski F-Score

Property, plant and equipment

$25.1M

Shareholders' equity

$171.8M

Tangible book value

$171.8M

Tangible book value per share

$6.04

Total assets

$224.3M

Total cash

$191.5M

Total debt

$22.9M

Total liabilities

$52.5M

WACC

16.77%

Metric	Value
Asset turnover	0.11
Current assets	$197.2M
Current liabilities	$33.5M
Current ratio	5.88
Net working capital	$-23.9M
Quick ratio	5.76
Working capital	$163.6M
Working capital turnover	0.15

Metric

Value

Asset turnover

0.11

Current assets

$197.2M

Current liabilities

$33.5M

Current ratio

5.88

Net working capital

$-23.9M

Quick ratio

5.76

Working capital

$163.6M

Working capital turnover

0.15

Metric	Value
Buyback yield / dilution	-3.47%
Dividend yield	0%
Shareholder yield	-3.47%

Metric

Value

Buyback yield / dilution

-3.47%

Dividend yield

Shareholder yield

-3.47%

Metric	Value
150-day SMA	$9.49
1D price change	7.39%
1M price change	-12.92%
1M total return	-12.92%
1W price change	8.94%
1W total return	8.94%
1Y price change	13.88%
1Y return CAGR	13.89%
1Y total return	13.88%
20-day SMA	$11.84
200-day SMA	$8.96
3M price change	109.38%
3M total return	109.38%
3Y price change	-34.49%
3Y return CAGR	-13.15%
3Y total return	-34.49%
50-day SMA	$13.57
50-day SMA vs 200-day SMA	50over200
52-week high	$17.96
52-week high date	2026-09-17
52-week low	$5.50
52-week low date	2026-07-24
5Y price change	-73.51%
5Y return CAGR	-23.34%
5Y total return	-73.51%
6M price change	45.3%
6M total return	45.3%
All-time high	$129.71
All-time high date	2020-12-07
All-time low	$4.11
All-time low date	2018-12-28
Average true range (ATR)	$1.09
Average volume	651K
Beta (1Y)	2.12
Beta (2Y)	2.42
Beta (5Y)	2.48
Change from 52-week high	-32.85%
Change from 52-week low	119.27%
Change from all-time high	-90.7%
Change from all-time low	193.43%
Change from open	3.61%
Day's gap	3.65%
Dollar volume	$7.1M
High price	$12.21
Low price	$11.27
Monthly RSI	48.01
Open price	$11.64
Position in 52-week range	84.04%
Premarket change	0.36%
Premarket close	$11.23
Premarket price	$11.27
Premarket volume	201
Previous close	$11.23
Price vs 150-day SMA	27.13%
Price vs 20-day SMA	1.82%
Price vs 200-day SMA	34.57%
Price vs 50-day SMA	-11.15%
Relative volume	0.92
RSI	50.42
Sharpe ratio	0.49
Sharpe ratio (3Y)	0.21
Sharpe ratio (5Y)	0.11
Sortino ratio	0.91
Sortino ratio (3Y)	0.38
Sortino ratio (5Y)	0.23
Volume	589.4K
Weekly RSI	53.97
YTD price change	96.74%
YTD total return	96.74%

Metric

Value

150-day SMA

$9.49

1D price change

7.39%

1M price change

-12.92%

1M total return

-12.92%

1W price change

8.94%

1W total return

8.94%

1Y price change

13.88%

1Y return CAGR

13.89%

1Y total return

13.88%

20-day SMA

$11.84

200-day SMA

$8.96

3M price change

109.38%

3M total return

109.38%

3Y price change

-34.49%

3Y return CAGR

-13.15%

3Y total return

-34.49%

50-day SMA

$13.57

50-day SMA vs 200-day SMA

50over200

52-week high

$17.96

52-week high date

2026-09-17

52-week low

$5.50

52-week low date

2026-07-24

5Y price change

-73.51%

5Y return CAGR

-23.34%

5Y total return

-73.51%

6M price change

45.3%

6M total return

45.3%

All-time high

$129.71

All-time high date

2020-12-07

All-time low

$4.11

All-time low date

2018-12-28

Average true range (ATR)

$1.09

Average volume

651K

Beta (1Y)

2.12

Beta (2Y)

2.42

Beta (5Y)

2.48

Change from 52-week high

-32.85%

Change from 52-week low

119.27%

Change from all-time high

-90.7%

Change from all-time low

193.43%

Change from open

3.61%

Day's gap

3.65%

Dollar volume

$7.1M

High price

$12.21

Low price

$11.27

Monthly RSI

48.01

Open price

$11.64

Position in 52-week range

84.04%

Premarket change

0.36%

Premarket close

$11.23

Premarket price

$11.27

Premarket volume

201

Previous close

$11.23

Price vs 150-day SMA

27.13%

Price vs 20-day SMA

1.82%

Price vs 200-day SMA

34.57%

Price vs 50-day SMA

-11.15%

Relative volume

0.92

RSI

50.42

Sharpe ratio

0.49

Sharpe ratio (3Y)

0.21

Sharpe ratio (5Y)

0.11

Sortino ratio

0.91

Sortino ratio (3Y)

0.38

Sortino ratio (5Y)

0.23

Volume

589.4K

Weekly RSI

53.97

YTD price change

96.74%

YTD total return

96.74%

Metric	Value
Float	26.2M
Float percentage	92.01%
Shares change (QoQ)	0.01%
Shares change (YoY)	3.47%
Shares held by insiders	7.99%
Shares held by institutions	75.41%
Shares outstanding	28.4M
Short % of float	20.56%
Short % of shares	18.92%
Short ratio	5.9 days

Metric

Value

Float

26.2M

Float percentage

92.01%

Shares change (QoQ)

0.01%

Shares change (YoY)

3.47%

Shares held by insiders

7.99%

Shares held by institutions

75.41%

Shares outstanding

28.4M

Short % of float

20.56%

Short % of shares

18.92%

Short ratio

5.9 days

Arcturus Therapeutics Holdings Inc. (ARCT)

Price

Financial snapshot

Fair-value bridge

Latest news · ARCT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ARCT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ARCT

Frequently asked questions